- Home
- ARQT vs ATEC Comparison
ARQT vs ATEC Comparison
Compare ARQT & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- ATEC
- Stock Information
- Founded
- ARQT 2016
- ATEC 1990
- Country
- ARQT United States
- ATEC United States
- Employees
- ARQT N/A
- ATEC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- ATEC Medical/Dental Instruments
- Sector
- ARQT Health Care
- ATEC Health Care
- Exchange
- ARQT Nasdaq
- ATEC Nasdaq
- Market Cap
- ARQT 1.7B
- ATEC 1.8B
- IPO Year
- ARQT 2020
- ATEC 2006
- Fundamental
- Price
- ARQT $13.82
- ATEC $10.94
- Analyst Decision
- ARQT Strong Buy
- ATEC Strong Buy
- Analyst Count
- ARQT 6
- ATEC 10
- Target Price
- ARQT $18.80
- ATEC $17.90
- AVG Volume (30 Days)
- ARQT 1.9M
- ATEC 1.5M
- Earning Date
- ARQT 08-13-2025
- ATEC 07-30-2025
- Dividend Yield
- ARQT N/A
- ATEC N/A
- EPS Growth
- ARQT N/A
- ATEC N/A
- EPS
- ARQT N/A
- ATEC N/A
- Revenue
- ARQT $212,819,000.00
- ATEC $642,265,000.00
- Revenue This Year
- ARQT $61.15
- ATEC $22.46
- Revenue Next Year
- ARQT $37.98
- ATEC $18.36
- P/E Ratio
- ARQT N/A
- ATEC N/A
- Revenue Growth
- ARQT 100.03
- ATEC 25.53
- 52 Week Low
- ARQT $7.86
- ATEC $4.88
- 52 Week High
- ARQT $17.75
- ATEC $13.14
- Technical
- Relative Strength Index (RSI)
- ARQT 50.73
- ATEC 36.02
- Support Level
- ARQT $12.97
- ATEC $10.66
- Resistance Level
- ARQT $13.84
- ATEC $11.23
- Average True Range (ATR)
- ARQT 0.61
- ATEC 0.48
- MACD
- ARQT 0.02
- ATEC -0.20
- Stochastic Oscillator
- ARQT 51.64
- ATEC 12.12
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ATEC Alphatec Holdings Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.